Home › Funds › MFS Investment Management › RIGL
MFS Investment Management position in RIGL
RIGEL PHARMACEUTICALS INC · Health Care
Latest position (Q2 2026)42.34K sh
Reported value held$1.66M
Portfolio Weight0.00%
First reportedQ1 2025
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 33.37K | $600.31K | New |
| Q2 2025 | 51.13K | $957.72K | Add |
| Q3 2025 | 54.73K | $1.55M | Add |
| Q4 2025 | 52.98K | $2.27M | Reduce |
| Q1 2026 | 44.03K | $1.19M | Reduce |
| Q2 2026 | 42.34K | $1.66M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding RIGL
- BlackRock Inc 1.94M sh · $75.89M · Q2 2026
- Vanguard Group 1.04M sh · $44.48M · Q4 2025
- D. E. Shaw & Co 542.54K sh · $21.22M · Q2 2026
- Geode Capital Management 483.18K sh · $18.91M · Q2 2026
- Marshall Wace 367.39K sh · $14.37M · Q2 2026
- Goldman Sachs Group 226.78K sh · $8.87M · Q2 2026
- Two Sigma Investments 207.58K sh · $8.12M · Q2 2026
- Morgan Stanley 186.05K sh · $7.28M · Q2 2026
- Charles Schwab Investment Management 154.63K sh · $6.05M · Q2 2026
- Northern Trust Corp 146.38K sh · $5.73M · Q2 2026
- Renaissance Technologies 145.85K sh · $5.71M · Q2 2026
- AQR Capital Management 124.80K sh · $4.88M · Q2 2026